ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,560,588, issued on Feb. 24, was assigned to KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (Daejeon, South Korea).

"High-efficiency screening method for RNA-targeting drugs using nanopores" was invented by Seung-Wook Chi (Daejeon, South Korea), Mi-Kyung Lee (Daejeon, South Korea), Donghwa Lee (Daejeon, South Korea) and Sohee Oh (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to nanopore-based technology for screening of drugs against target RNA. According to the screening method of the disclosure, drugs targeting RNA can be efficiently screened even with a very small amount sample of picomolar concen...